Poractant alfa - Respiratory distress in preterm neonates
You are here : Home > Formulary Search > Poractant alfa - Respiratory distress in preterm neonates
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Poractant alfa
Indication :
Respiratory distress in preterm neonates
Group Name :
Keywords :
Brand Names Include :
Curosurf
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Poractant alfa is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Respiratory distress in preterm neonates.
- No records returned.
Committee Recommendations (1)
01 Apr 13 -
Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.